MDR1 Gene Expression: Evaluation of its Use as a Molecular Marker for Prognosis and Chemotherapy of Bone and Soft Tissue Sarcomas

Author： Stein U.   Shoemaker R.H.   Schlag P.M.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.32, Iss.1, 1996-01, pp. : 86-92

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Histology-Driven Chemotherapy in Soft Tissue Sarcomas

By Scurr Michelle  

Current Treatment Options in Oncology, Vol. 12, Iss. 1, 2011-03 ,pp. : 32-45

Springer Publishing Company

Access to resources Recommend Favorite

Treating soft tissue sarcomas with adjuvant chemotherapy

By Patrikidou Anna  

Current Treatment Options in Oncology, Vol. 12, Iss. 1, 2011-03 ,pp. : 21-31

Springer Publishing Company

Access to resources Recommend Favorite

Long-term neurotoxicity of chemotherapy in adolescents and young adults treated for bone and soft tissue sarcomas

By Earl Helena M.   Connolly Sean   Latoufis Christos   Eagle Karen   Ash Catherine M.   Fowler Clare   Souhami Robert L.  

Sarcoma, Vol. 2, Iss. 2, 1998-06 ,pp. : 97-105

Informa Healthcare

Access to resources Recommend Favorite

Ki67 and CD100 immunohistochemical expression is associated with local recurrence and poor prognosis in soft tissue sarcomas, respectively

By                      

Oncology Letters, Vol. 5, Iss. 5, 2013-01 ,pp. : 1527-1535

Spandidos Publications

Access to resources Recommend Favorite

Soft Tissue and Bone Sarcomas in Association with Pregnancy

By Merimsky Ofer   Le Cesne Axel  

Acta Oncologica, Vol. 37, Iss. 7-8, 1998-12 ,pp. : 721-727

Informa Healthcare

Access to resources Recommend Favorite